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The past decade has been characterized by increased scrutiny of outcomes of surgical and percutaneous coronary 
interventions (PCIs). This increased scrutiny has led to the development of regional, state, and national databases 
for outcome assessment and for  public reporting. This report describes the initial development of a regional, 
collaborative, cardiovascular consortium and the progress made so far  by this collaborative group. In 1997, a 
group of hospitals in the state Michigan agreed to create a regional collaborative consortium for  the development 
of a quality improvement program in interventional cardiology. The project included the creation of a 
comprehensive database of PCIs to be used for risk assessment, feedback on absolute and risk-adjusted outcomes, 
and sharing of information. To date, information from nearly 20,000 PCIs have been collected. A risk prediction 
tool for death in the hospital and additional risk prediction tools for other outcomes have been developed from the 
data collected, and are currently used by the participating centers for risk assessment and for  quality improvement. 
As the project enters into year 5, the participating centers are deeply engaged in the quality improvement phase, 
and expansion to a total of I7 hospitals with active PCI programs is in process. In conclusion, the Blue Cross Blue 
Shield of Michigan Cardiovascular Consortium is an example of a regional collaborative effort to assess and 
improve quality of care and outcomes that overcome the barriers of traditional market and academic competition. 
( J  Interven Cardiol2002;15:381-386) 
Introduction 
Since its initial introduction in 1977 by Gruentzig,' 
advancements in catheter technology and improved 
operator techniques have resulted in a continuous 
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growth of percutaneous transluminal coronary angio- 
plasty (PTCA), with initial success rates > 90% and 
major complication rates C 5%.2*3 The approval of 
new devices for coronary interventions, and in partic- 
ular of coronary stents, has further expanded the capa- 
bilities of percutaneous coronary interventions (PCIs). 
Indeed, it was estimated that in the year 1994, > 
400,000 PTCAs were performed in the United States: 
with PTCA surpassing coronary artery bypass surgery 
as a primary treatment for coronary artery disease. 
More recent estimates suggest > 600,000 procedures 
were performed in the United States in 1998.5 
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While the value of PTCA as an alternative to coro- 
nary artery bypass surgery and to medical treatment 
for symptomatic patients with coronary artery disease 
has been well documented in multiple studies,Gg the 
procedure is associated with a small, though not in- 
significant risk of morbidity and mortality, and with 
high costs related to equipment use, professional fees, 
and need for hospitalization. Variation in the outcomes 
of PCIs among different operators and centers may de- 
pend on multiple factors including the characteristics 
of the patient population treated (i.e., sicker patients 
are more likely to have worse opera- 
tors’ and procedure and postprocedure vari- 
ables. A better understanding of how these factors in- 
teract can lead to a “risk-adjusted‘’ comparison of the 
results of different operators and centers, and may fos- 
ter improvement in the quality of care delivered 
through the implementation of practice guidelines, 
critical pathways, and “best practice strategies.” 
With a rapidly evolving field like interventional car- 
diology, single centers will not have adequate volume 
to quickly assess the effect of new modalities on pa- 
tient outcomes in a timely fashion, or to assess the re- 
lationship between risk factors and rare complications 
with an adequate statistical power. In addition, without 
the ability to benchmark with other institutions, it will 
be difficult if not impossible to assess the effect of 
practice variations on outcomes. The objective of the 
project was to develop a regional multicenter PCI reg- 
istry for the development and validation of risk-adjust- 
rnent models for fatal and nonfatal outcomes of PCIs, 
and to develop a continuous quality improvement 
(CQI) program by which institutions participating in 
this project could be provided with feedback on their 
absolute and risk-adjusted outcomes, on resource use, 
and with the opportunity to identify potentially cor- 
rectable factors associated with worse outcomes. This 
article describes the initial development of the authors 
regional, collaborative, cardiovascular consortium and 
the progress made so far by this collaborative group. 
Development of the Consortium 
In July 1996, 16 hospitals in the state of Michigan 
were invited to participate in a regional cardiovascular 
consortium. The goals of the project were to develop 
risk-adjustment models for fatal and nonfatal out- 
comes of PCIs, to analyze practice variation in PCIs, to 
provide feedback to individual operators and institu- 
tions on absolute and risk-adjusted outcomes, to de- 
velop evidence-based standardized patient care guide- 
lines, and to improve the quality of care of patients un- 
dergoing PCIs by sharing of information and a CQI 
process. Nine centers agreed to participate in the con- 
sortium. A common data collection form and a stan- 
dard set of definitions were developed, and a pilot 1- 
month data collection phase begun in July of 1997. Af- 
ter the pilot data collection the data form was further 
refined. The full data collection phase began in De- 
cember 1997 and it has been ongoing since then. As of 
March 2001, data on > 19,000 consecutive procedures 
have been collected. Of the nine initial centers, three 
centers did not enter into the second phase of the study 
because of lack of resources for the data collection. 
Two of these three centers reentered in the consortium 
during the third year (Fig. 1). 
Structure of the Consortium 
The Blue Cross Blue Shield of Michigan Cardiovas- 
cular Consortium (BMC2) includes academic and 
nonacademic centers in the state of Michigan that are 
part of the Blue Cross Blue Shield of Michigan Cardio- 
vascular Centers of Excellence Network. The initial 
proposal to include the Cardiac Centers of Excellence 
was felt to have added value because all institutions 
taking part in the Centers of Excellence Network had 
initiated internal efforts toward a better understanding 
of factors affecting outcomes and quality. Thus, it was 
felt that a collaborative effort between these centers 
could lead to a more rapid and accurate collection of 
meaningful data, and to more rapid and widespread un- 
derstanding of and improvements in practice.15 
The current structure of BMC2 includes an execu- 
tive committee (a physician and an hospital adminis- 
trator representative from each site), a working group 
(physician, nurse coordinator, and administrator from 
each site), and a writing committee (one physician rep- 
resentative from each site). The BMC2 Working 
Group currently meets two to three times per year to 
discuss the progress of the registry, resolve any issues 
with data collection or validation, and discuss findings 
of the registry. The role of the writing committee is to 
oversee any issue pertaining to in-depth analysis of the 
data and the reporting and publication in peer-re- 
viewed forums of the findings of the collaborative pro- 
ject. Participation in the consortium is currently vol- 
untary. 
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Figure 1. Map of the state of Michigan with name and geographic location of participating hospitals. 
Data Collection Quarterly Reports 
A nine-page report for individual operators and in- 
stitutions is prepared by the coordinating center every 
3 months and mailed to the participating hospitals. The 
report includes comorbidities, resource use, indication 
for the procedure, procedural variables, and outcome 
variables. The report has three columns. The first col- 
umn has individual operator summary statistics, the 
second column has institution summary statistics, and 
the third column has summary statistics from the con- 
sortium (Fig. 2). This report allows individual opera- 
tors to "benchmark" their practice with their institution 
and with the consortium. A summary report with ag- 
gregate data by calendar year is mailed at the end of 
the year. The reports are currently used by the partici- 
pating centers for morbidity and mortality confer- 
ences, internal review, reporting to other agencies, and 
to guide internal CQI activities. Because of confiden- 
tiality issues, the reports do not include direct physi- 
cian or institution identifiers. Each center has elec- 
tronic access to all of its own data for internal analysis 
and trend reporting. 
The data collection process and data quality assur- 
ance efforts are described in detail elsewhere. In brief, 
each center has a dedicated data collection person. A 
data form is compiled for each procedure. Data quality 
and the inclusion of consecutive procedures is assured 
by site visits, ad hoc queries, random chart review, and 
a series of diagnostic routines included in the database. 
This process assures data integrity, accuracy, and 
completeness, which are vital to the clinically detailed, 
rigorous analyses performed, and it is currently not 
matched in global and national cardiac procedure 
databases. 
Quality Improvement Phase 
The ultimate goal of this collaborative effort is to 
improve the quality of care of patients undergoing 
PCIs. It is important to underscore that quality im- 
provement does not imply poor baseline quality of 
care, but it rather implies that the identification of pre- 
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Blue Cross Blue Shield of Michigan 03/26/2001 BMC2 
Cardiovascular Consortium 
Patient Demographics Report (sample) 
Hospital Code: 99 
_ _  . - . _ _  ---- 
Physician 's ID: 9999 
- .. . _ _  . .. I .. . .. .- ._ 1 -. . . rataent vamwle comboratwe hrosvltar rnvsicwn 
Patients Enrolled n= 492 na 45 n= 10 
63.5 +/- 12.2 -64.1 +I- 32.8 63.8 +/- 13.1 Average Age . .. _ _  _ _  
Gender: (# + % Males) 330 67.1% 30 66.7% 9 90.0% 
Hypertension 345 70.1% 32 71.1% 7 70.0% 
Diabetes 122 24.8% 9 20.0% 1 10.0% 
Hx CHF 81 12.4% 8 17.8% 1 10.0% 
COPD 51 10.4% 2 4.4% 0 0.0% 
CVAKIA 44 8.g% 4 8.9% 1 10.0% 
Hx Cardiac Arrest 8 1.6% 2 4.4% 1 10.0% 
Prev MI: 148 30.1% 11 24.4% 4 40.0% 
Prev PTCA 178 35.8% 12 26.7% 4 40.0% 
Prev CABG (>O) 90 18.3% 8 17.8% 5 50.0% 
Conildential: For Quality Assurance Work ONLY 
This report covers the time period from: 07/01/2000 to: 08/01/2000 
Figure 2. Representative sample of quarterly report (baseline demographic table). 
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viously unknown risk factors or practice variations re- 
lated to adverse events can result in modification in 
practice leading to improved outcomes. The process 
followed is similar to the process that was followed by 
the Northern New England Cardiovascular Study 
Group for its quality improvement initiative in coro- 
nary artery bypass surgery.I6 In their study, apreinter- 
vention period of data collection for patients undergo- 
ing coronary artery bypass surgery was followed by 
feedback on outcome data, training in quality im- 
provement, and site visits. During the postintervention 
period, there was a 24% reduction in hospital mortal- 
ity (P = 0.001). The reduction in hospital mortality 
was consistent among patient subgroups and was tem- 
porally associated with the intervention. 
In the present study, participating institutions are 
provided feedback on their absolute and risk-adjusted 
outcomes. New findings pertaining to outcome analy- 
sis are shared with the participating centers during 
quarterly meetings and through a newsletter. The 
group has so far identified significant practice varia- 
tions in use of resources and variation in some of the 
outcome variables. These variations are currently the 
focus of the quality improvement phase. A risk-adjust- 
ment model for death in the hospital and a risk predic- 
tion rule for individual patients have been developed. 
This bedside risk prediction tool allows an informed 
discussion with the patients and with their families re- 
garding prognosis before and after percutaneous 
revascularization procedures. l7 Additional risk predic- 
tion rules for other fatal and nonfatal complications are 
currently under development. For example, contrast- 
induced nephropathy requiring dialysis is a rare com- 
plication of coronary revascularization procedures that 
is associated with a high in-hospital mortality rate. A 
risk prediction rule that allows the identification of pa- 
tients who might be at higher risk of developing this 
complication has been developed and it is currently 
used by participating physicians. Identification of pa- 
tients at increased risk should lead to modifications in 
procedural strategies aimed toward the prevention of 
this complication (e.g., maximizing hydration before 
the procedure, minimizing of the amount of contrast 
administered through special angiographic techniques, 
precise calculation of maximal allowable contrast dose 
for individual patients). The same process has been ap- 
plied to other complications like bleeding complica- 
tions, transfusion requirement, and emergency or ur- 
gent coronary artery bypass grafting (CABG) follow- 
ing coronary interventions. 
Formal exposure to the CQI method supports the 
development and application of guidelines and path- 
ways, and provides the opportunity to identify poten- 
tially correctable variables and to reassess outcomes 
during a postintervention phase. Assessment of appro- 
priateness of procedures performed will be part of this 
quality improvement process. 
The quality improvement process includes site vis- 
its for comparison of the care process and for exchange 
of information. During these site visits, the host is in- 
structed to continue with “business as usual” while the 
guest is instructed to “compare with home.” Three site 
visits have been completed so far. These site visits are 
in addition to the routine site visits that are performed 
twice a year by the clinical coordinator for data quality 
assurance and for assessment of data integrity. They 
are generating additional information on variations in 
care processes and a true spirit of collaboration among 
the participating hospitals, all of which serves as a 
stimulus to rapid cycle quality improvement. 
Future Developments 
As the project moves into the year 5 ,  the Blue Cross 
Blue Shield of Michigan PPO intends to expand par- 
ticipation in the BMC2 project to all Blue Cross Blue 
Shield of Michigan Cardiac Centers of Excellence. 
This expansion will occur through funding of data col- 
lection at the participating institutions by Blue Cross 
Blue Shield of Michigan. When this expansion is com- 
pleted, the project will include up to 17 hospitals, mak- 
ing it a compelling and unique example of collabora- 
tive efforts between payers and providers designed to 
assess outcomes, correlate them with care processes, 
and use the learning achieved to guide quality im- 
provement. 
Conclusions 
The past decade has been characterized by increased 
scrutiny of outcomes of surgical and percutaneous car- 
diovascular procedures. This increased scrutiny has 
led to the development of regional, state, and national 
databases for outcome assessment and for public re- 
porting. The BMC2 is an example of a regional col- 
laborative effort to assess and improve quality of care 
and outcomes which overcomes the barriers of tradi- 
tional market and academic competition. Based on the 
BMC2 INITIATIVE IN PCI 
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progress achieved by the collaborative group so far, it 
is anticipated that this effort will result in improved 
outcomes and decreased costs of PCIs in the state of 
Michigan. 
Appendix 
BMC2 Hospitals and Working Group Members. 
University of Michigan Health System in Ann Arbor 
(BMC2 Coordinating Center): Kim A. Eagle, M.D., 
F.A.C.C., Mauro Moscucci, M.D., Eva Kline-Rogers, 
M.S., R.N., Diane Bondie, B.S., Bruce Rogers B.S., 
Jeanna Cooper, M.S.; Blue Cross Blue Shield of Michi- 
gan: David Share, M.D.; Northern Michigan Hospitals 
in Petoskey: William Meengs, M.D., Robert Sloan, 
M.B.A., Cindy Bodurka, R.N.; Spectrum Health 
Downtown in Grand Rapids: William McNamara, 
M.D., Ann Maxwell-Eward, Ph.D., Sherri Kanten, 
R.N., Renee Stamper, J.D.; McLuren Regional Medi- 
cal Center in Flint: Anthony DeFranco, M.D., 
F.A.C.C., James Chambers, D.O., Cathy Fisk, R.N., 
L i s a  Pertler, R.N., Stacey Somsky, R.N.; St. Joseph 
Mercy Hospital in Ann Arbor: Michael O'Donnell, 
M.D., Patricia Wren, R.N.; St. Joseph Mercy Hospital 
in Pontiac: Kirit Patel, M.D., Susan Wright, R.N., 
Bethany Smith, R.N.; Harper Hospital in Detroit: 
John McGinnity, M.S., P.A.-C., Cathy June, R.N.; 
Henry Ford Hospital in Detroit: Vivian L. Clark, 
M.D., Phillip Kraft, M.D., Laurel Dvorak, R.N., Kelly 
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